PRONOUNCE: comparing cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and cardiovascular disease
30 August 2021 (14:30 - 14:45)
Organised by:
Slides
About the speaker
Duke University Medical Center, Durham (United States of America)
2 More presentations in this session
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
30 August 2021
14:30 CET
You may be interested in
Webinar
18 November 2025
Congress Session
27 August 2022
Congress Presentation
Congress Presentation
